Cargando…

Safety of low-dose subcutaneous recombinant interleukin-2: systematic review and meta-analysis of randomized controlled trials

Standard-dose intravenous recombinant interleukin-2 (rIL-2) is indicated for the treatment of some subtypes of cancer; however, severe adverse events, including venous thromboembolism (VTE), may complicate its administration. Low-dose subcutaneous rIL-2 is being studied for the management of immune-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mahmoudpour, Seyed Hamidreza, Jankowski, Marius, Valerio, Luca, Becker, Christian, Espinola-Klein, Christine, Konstantinides, Stavros, Quitzau, Kurt, Barco, Stefano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6509335/ https://www.ncbi.nlm.nih.gov/pubmed/31073219 http://dx.doi.org/10.1038/s41598-019-43530-x

Ejemplares similares

Prognostic value of right ventricular dysfunction or elevated cardiac biomarkers in patients with low-risk pulmonary embolism: a systematic review and meta-analysis
por: Barco, Stefano, et al.
Publicado: (2019)

Sterblichkeit der Lungenembolie in der DACH-Region
por: Hobohm, Lukas, et al.
Publicado: (2021)

Recurrence Risk after First Symptomatic Distal versus Proximal Deep Vein Thrombosis According to Baseline Risk Factors
por: Valerio, Luca, et al.
Publicado: (2019)

Trends and Risk Factors of In-Hospital Mortality of Patients with COVID-19 in Germany: Results of a Large Nationwide Inpatient Sample
por: Hobohm, Lukas, et al.
Publicado: (2022)

Predisposing factors for admission to intensive care units of patients with COVID-19 infection—Results of the German nationwide inpatient sample
por: Keller, Karsten, et al.
Publicado: (2023)

Age-sex specific pulmonary embolism-related mortality in the USA and Canada, 2000–18: an analysis of the WHO Mortality Database and of the CDC Multiple Cause of Death database
por: Barco, Stefano, et al.
Publicado: (2021)

Performance Status and Long-Term Outcomes in Cancer-Associated Pulmonary Embolism: Insights From the Hokusai-VTE Cancer Study
por: Farmakis, Ioannis T., et al.
Publicado: (2022)

COVID-19 infection and its impact on case fatality in patients with pulmonary embolism
por: Hobohm, Lukas, et al.
Publicado: (2023)

Pulmonary Embolism: Contemporary Medical Management and Future Perspectives
por: Barco, Stefano, et al.
Publicado: (2018)

Catheter-directed thrombolysis for acute pulmonary embolism: Where do we stand?
por: Barco, Stefano, et al.
Publicado: (2017)

Thrombosis and thromboembolism related to COVID‐19: A clarion call for obtaining solid estimates from large‐scale multicenter data
por: Barco, Stefano, et al.
Publicado: (2020)

Incidence of acute pulmonary embolism in COVID-19 patients: Systematic review and meta-analysis.
por: Roncon, Loris, et al.
Publicado: (2020)

Subcutaneous low-dose recombinant interleukin 2 and alpha-interferon in patients with metastatic renal cell carcinoma.
por: Ravaud, A., et al.
Publicado: (1994)

Regression of established pulmonary metastases and subcutaneous tumor mediated by the systemic administration of high-dose recombinant interleukin 2
Publicado: (1985)

Social determinants of health in pulmonary embolism management and outcome in hospitals: Insights from the United States nationwide inpatient sample
por: Farmakis, Ioannis T., et al.
Publicado: (2023)

Antithrombotics and new interventions for venous thromboembolism: Exploring possibilities beyond factor IIa and factor Xa inhibition
por: Mavromanoli, Anna C., et al.
Publicado: (2021)

Recombinant human interleukin 4 (IL-4) given as daily subcutaneous injections--a phase I dose toxicity trial.
por: Gilleece, M. H., et al.
Publicado: (1992)

Cost‐of‐Illness Analysis of Long‐Term Health Care Resource Use and Disease Burden in Patients With Pulmonary Embolism: Insights From the PREFER in VTE Registry
por: Farmakis, Ioannis T., et al.
Publicado: (2022)

Increased interest in acute pulmonary embolism in Italy during the COVID-19 pandemic: a google trends-based analysis
por: Roncon, Loris, et al.
Publicado: (2020)

Risk of venous thromboembolic events after COVID-19 infection: a systematic review and meta-analysis
por: Zuin, Marco, et al.
Publicado: (2023)

Fatality rates and use of systemic thrombolysis in pregnant women with pulmonary embolism
por: Hobohm, Lukas, et al.
Publicado: (2020)

Cardiac and Cerebral Arterial Complications of Lemierre Syndrome: Results from a Systematic Review and Individual Patient Data Meta-analysis
por: Pleming, William, et al.
Publicado: (2022)

Equivalent doses for anticancer agents used in pediatric oncology: A literature review and evaluation of a novel approach for conversion factors
por: Ressing, Meike, et al.
Publicado: (2023)

Deaths related to pulmonary embolism and cardiovascular events before and during the 2020 COVID-19 pandemic: An epidemiological analysis of data from an Italian high-risk area
por: Voci, Davide, et al.
Publicado: (2022)

Editorial: Pharmacogenomics of Adverse Drug Reactions
por: Siddiqui, Moneeza K., et al.
Publicado: (2022)

Global reporting of pulmonary embolism–related deaths in the World Health Organization mortality database: Vital registration data from 123 countries
por: Barco, Stefano, et al.
Publicado: (2021)

The clinical effects of prolonged treatment of patients with advanced cancer with low-dose subcutaneous interleukin-2 [corrected]
por: Stein, R. C., et al.
Publicado: (1991)

The 2019 European guidelines on pulmonary embolism illustrated with the aid of an exemplary case report
por: Gallo, Andrea, et al.
Publicado: (2021)

In-hospital fatality and venous thromboembolism during the first and second COVID-19 waves at a center opting for standard-dose thromboprophylaxis
por: Mumoli, Nicola, et al.
Publicado: (2021)

Immediate and late impact of reperfusion therapies in acute pulmonary embolism
por: Valerio, Luca, et al.
Publicado: (2019)

Comparison of Oral Recombinant Erythropoietin and Subcutaneous Recombinant Erythropoietin in Prevention of Anemia of Prematurity
por: Saeidi, R, et al.
Publicado: (2012)

Cardiopulmonary exercise testing during follow-up after acute pulmonary embolism
por: Farmakis, Ioannis T., et al.
Publicado: (2023)

Venous thromboembolism in patients hospitalized for knee joint replacement surgery
por: Keller, Karsten, et al.
Publicado: (2020)

Immunotherapy with low-dose recombinant interleukin 2 after high-dose chemotherapy and autologous stem cell transplantation in neuroblastoma.
por: Pession, A., et al.
Publicado: (1998)

Immunotherapy with subcutaneous low-dose interleukin-2 and the pineal indole melatonin as a new effective therapy in advanced cancers of the digestive tract.
por: Lissoni, P., et al.
Publicado: (1993)

A randomised dose escalation study of subcutaneous interleukin 2 with and without levamisole in patients with metastatic renal cell carcinoma or malignant melanoma.
por: Ahmed, F. Y., et al.
Publicado: (1996)

Therapeutic effect of subcutaneous injection of low dose recombinant human granulocyte-macrophage colony-stimulating factor on pulmonary alveolar proteinosis
por: Zhang, Fen, et al.
Publicado: (2020)

A review of consecutive cardiac arrests in 2007 and 2012 at a regional hospital in Denmark: a retrospective cohort study
por: Quitzau, Lisbeth, et al.
Publicado: (2013)

Analgesic Effect of Low Dose Subcutaneous Ketamine Administration Before and After Cesarean Section
por: Behaeen, Kaveh, et al.
Publicado: (2014)

A randomised study with subcutaneous low-dose interleukin 2 alone vs interleukin 2 plus the pineal neurohormone melatonin in advanced solid neoplasms other than renal cancer and melanoma.
por: Lissoni, P., et al.
Publicado: (1994)

Cannot write session to /tmp/vufind_sessions/sess_ihu5d6qq6j7k0edm0afipn7613